期刊文献+

90K/Mac-2 BP在人脑星形细胞瘤中的表达 被引量:4

Expression of 90K/Mac-2 BP in human brain astrocytic tumors
下载PDF
导出
摘要 目的分析90K/Mac-2 BP(Mac-2 binding protein)在人脑星形细胞瘤中的表达。方法 RT-PCR和WB(Western blot)检测90 K蛋白在人脑星形细胞瘤以及正常脑组织中的表达。结果 RT-PCR发现90 K mRNA在正常脑组织中微量表达,相对表达量为0.116±0.017;而在人脑星形细胞瘤中高表达,相对表达量为0.407±0.151,两组相比有显著差异(t=6.065,P<0.05)。低级别组(WHO Ⅰ-Ⅱ级)与高级别组(WHO Ⅲ-Ⅳ级)相对表达量分别为0.295±0.067和0.516±0.128,两组相比有显著差异(t=8.138,P<0.05)。WB发现90 K蛋白在正常脑组织中微量表达,相对表达量为0.291±0.064,星形细胞瘤中90 K蛋白相对表达量为1.163±0.391,两组相比有显著差异(t=15.68,P<0.05)。低级别组与高级别组90K蛋白相对表达量分别为0.902±0.272和1.415±0.318,两组相比有显著差异(t=6.539,P<0.05)。WB结果表明90 K蛋白在星形细胞瘤中的表达情况与RT-PCR结果表明90 K mRNA在星形细胞瘤中的表达情况一致。结论 90K在星形细胞瘤中的表达显著升高,高级别星形细胞瘤中的表达较低级别更高,提示90K可能在星形细胞瘤的发生发展过程中发挥了重要作用,90K蛋白可能是星形细胞瘤相关抗原,在今后的免疫治疗中可能作为一种目标抗原。 Objective To investigate the expression of 90K mRNA and protein in human brain astrocytomas. Methods The expression of 90K mRNA in human normal brain tissue and astrocytoma tissue was detected by RT-PCR; The expression of 90K protein in human normal brain tissue and astrocytoma tissue was detected by WB. Results RT-PCR reveal that 90K mRNA was lowly expressed in normal human brain tissues (0.116 ± 0.017 ). The 90K mRNA expression was significantly higher in astrocytomas (0. 407 ± 0.151 ) than that in normal human brain tissues ( t = 6. 065, P 〈 0.05 ), and significantly higher in high grade astrocytomas ( WHO III-IV ) (0.516 ± 0. 128 ) than in low grade( WHO I-II) (0.295 ± 0. 067) (t = 8. 138, P 〈 0.05 ). WB reveal that 90K protein was lowly expressed in normal human brain tissues (0. 291 ± 0. 064 ). The 90K protein expression was significantly higher in astrocytomas ( 1. 163 ± 0.391 ) than that in normal human brain tissues ( t = 15.68, P 〈 0.05 ), and significantly higher in high grade astrocytomas ( 1. 415 ± 0.318 ) than in low grade (0.902 ± 0.272 ) (t = 6. 539, P 〈 0.05 ). The expression of 90K mRNA was in accordance with the expression of 90K protein both in astrocytomas and normal human brain tissues. Conclusions 90K expressed positive in astrocytomas. The expression of 90K is higher in higher grade astrocytomas. 90K may contribute to occurrence and progression of astrocytomas. 90K protein may be a astrocytomas-associated antigen and target antigen in immunotberapy.
出处 《国际神经病学神经外科学杂志》 2012年第5期395-399,共5页 Journal of International Neurology and Neurosurgery
关键词 90K Mac-2 BP 星形细胞瘤 RT-PCR WESTERN BLOT 90K/Mac-2 BP astrocytomas RT-PCR Western blot
  • 相关文献

参考文献30

  • 1Okada H,Kohanbash G,Zhu X , et al . Immunotherapeuticapproaches for glioma. Crit Rev Immunol, 2009,29(1):1-42.
  • 2Gonzalez-Gomez P,Bello MJ,Aijona D , et al. Promoter hy-permethylation of multiple genes in astrocytic gliomas. Int JOncol, 2003,22(3) : 601-608.
  • 3Ullrich A,Sures I, D ’ Egidio M,et al. The secreted tumor-associated antigen 90K is a potent immune stimulator. J BiolChem, 1994, 269(28) : 18401-18407.
  • 4Koths K,Taylor E,Halenbeck R,et al. Cloning and charac-terization of a human Mac-2-binding protein , a new memberof the superfamily defined by the macrophage scavenger receptorcysteine - rich domain. J Biol Chem,1993,268 ( 19):14245-14249.
  • 5Tinari N , Kuwabara I,Huflejt ME , et al. Glycoprotein 90K/MAC -2 BP interacts with galectin -1 and mediates galectin -1 -induced cell aggregation. Int J Cancer, 2001,91(2):167-172.
  • 6Andr6 S , Pieters RJ , Vrasidas I,et al. Wedgelike glycoden-drimers as inhibitors of binding of mammalian galectins to gly-coproteins ,lactose maxiclusters, and cell surface glycocon-jugates. Chembiochem , 2001,2(11) : 822-830.
  • 7Resnick D,Pearson A,Krieger M. The SRCR superfamily : afamily reminiscent of the Ig superfamily. Trends Biochem Sci,1994, 19(1 ) : 5-8.
  • 8Sasaki T , Brakebusch C , Engel J , et al.,Mac-2 bindingprotein is a cell - adhesive protein of the extracellular matrixwhich self-assembles into ring-like structures and binds betalintegrins, collagens and fibronectin. EMBO J, 1998 , 17(6) : 1606-1613.
  • 9Iacobelli S,Am6 E , D,Orazio A,et al. Detection of anti-gens recognized by a novel monoclonal antibody in tissue andserum from patients with breast cancer. Cancer Res , 1986,46(6) : 3005-3010.
  • 10Artini M , Natoli C , Tinari N,et al. Elevated serum levels of90 K/MAC-2 BP predict unresponsiveness to alpha - interferontherapy in chronic HCV hepatitis patients. J Hepatol, 1996,25(2) : 212-217.

同被引文献47

  • 1Ping Feng,Zhi-Lin Zhang,Zhi-Hua Zhang,Xiu-Long Zhang,Feng Xiang,Jian-Hua Tang,Bao-Li Xiang.Effect of endostar combined with cisplatin on expression of VEGF and Sema3A of Lewis lung cancer rats[J].Asian Pacific Journal of Tropical Medicine,2013,6(1):57-60. 被引量:14
  • 2王文武,戴西湖,欧阳学农.川芎嗪对小鼠Lewis肺癌的治疗作用[J].中国临床药理学与治疗学,2005,10(4):421-423. 被引量:10
  • 3杜国平,张炜,王丽,刘银坤,周剑萍.凝集素半乳糖结合蛋白3在人子宫内膜的表达[J].复旦学报(医学版),2006,33(2):143-146. 被引量:12
  • 4张隽,曹培国,符慧群,唐又群,潘宇亮.川芎嗪联合顺铂治疗Lewis肺癌的实验研究[J].医学临床研究,2006,23(8):1249-1251. 被引量:8
  • 5Wolfe SQ, BruceJ, MorcosJ J. Pituicytoma , case report. Neurosurgery, 2008, 63 (1 ) : 173 -174.
  • 6Secci F, Merciadri P, Rossi DC, et al. Pituicytomas , radiological findings, clinical behavior and surgical management. Acta Neurochir, 2012,154(4) :649-657.
  • 7GondimJA, Schops M, de AlmeidaJP. Endoscopic endonasal transsphenoidal surgery: surgical results of 228 pituitary adenomas treated in a pituitary center. Pituitary, 20 1 0 , 13(1):68-77.
  • 8Brat OJ, Scheithauer BW, Staugaitis SM, et al. Pituicytoma : a distinctive low - grade gliomaof the neurohypophysis. AmJ Surg Pathol ,2000,24(3) :362-368.
  • 9Louis ON, Ohgaki H, Wiestler 00, et al. The 2007 WHO ClassiW cation of Tumours of the Central Nervous System. Acta Neuropathol ,2007,114(2) :97-109.
  • 10Brat OJ, Scheithauer BW, Fuller GN, et al. Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentr ic glioma, pilomyxoi d astrocytoma and pituicytoma. Brain Pathol ,2007, 17(3) :319-324.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部